ADVFN US – Market Content Editor
-

RH slides as real estate chief departs for Crate & Barrel
Shares of RH (NYSE:RH) moved lower in premarket trading, falling 1.3%, after the luxury home furnishings group announced the departure of another senior executive, extending a recent run of leadership changes. Steve Rouman, the company’s Senior Vice President of Real Estate, has stepped down to take on the role of Chief Real Estate & Development…
-

Duke Energy narrowly beats Q4 profit forecasts, outlook tracks expectations
Duke Energy (NYSE:DUK) reported fourth-quarter earnings on Tuesday that came in just ahead of analyst estimates, while issuing 2026 guidance broadly in line with market expectations. The utility’s shares dipped 0.18% in pre-market trading following the release. For the fourth quarter of 2025, Duke Energy posted adjusted earnings per share of $1.50, edging past consensus…
-

Fiserv tops Q4 profit forecasts as revenue narrowly misses; shares little changed
Fiserv, Inc. (NASDAQ:FISV) posted fourth-quarter adjusted earnings on Tuesday that came in ahead of Wall Street expectations, even as revenue fell just short of forecasts. The payments and financial technology group’s shares were little changed in pre-market trading, slipping 0.23% following the results. Adjusted earnings per share for the quarter totaled $1.99, above the analyst…
-

Vestis falls short in Q1 as weaker revenue drags earnings
Vestis Corporation (NYSE:VSTS) reported first-quarter fiscal 2026 results on Tuesday that missed market expectations, as softer revenue weighed on profitability. The uniform and workplace supplies provider posted adjusted earnings of $0.10 per share, well below the analyst consensus of $0.27. Revenue totaled $663.4 million, missing forecasts of $763.69 million and marking a 3% year-on-year decline.…
-

Nektar gains after durable efficacy shown in atopic dermatitis study
Shares of Nektar Therapeutics (NASDAQ:NKTR) moved higher on Tuesday after the company released encouraging long-term maintenance results from its REZOLVE-AD trial of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis. The stock was up about 3% in morning trading. The clinical-stage biotech said patients receiving rezpegaldesleukin, a regulatory T-cell–targeting biologic, sustained strong clinical responses through week…
-

Entegris jumps after Q4 beat and upbeat Q1 guidance
Entegris, Inc. (NASDAQ:ENTG) shares surged on Tuesday after the company reported fourth-quarter results that came in ahead of expectations and issued stronger-than-anticipated guidance for early 2026. The advanced materials supplier’s stock rose 6.99% in pre-market trading following the announcement. For the quarter, Entegris delivered adjusted earnings of $0.70 per share, topping the analyst consensus of…
-

Unity shares jump after Oppenheimer upgrade highlights AI upside
Unity Software (NYSE:U) climbed about 5% in Tuesday morning trading after Oppenheimer upgraded the stock to Outperform from Perform and introduced a $38 price target. The call comes after a tough stretch for Unity, which has lagged amid broader weakness in software names tied to concerns around artificial intelligence. The stock finished Monday at $27.53,…
-

Incyte slips after Q4 profit miss despite strong sales growth
Incyte Corporation (NASDAQ:INCY) posted fourth-quarter results on Tuesday that showed a miss on earnings, overshadowing a solid revenue beat and pushing the stock lower in premarket trading. Shares were down 4.57% following the announcement. The biopharmaceutical group reported adjusted earnings of $1.80 per share for the quarter, below the analyst consensus of $1.91. Revenue, however,…
-

Datadog shares surge after Q4 earnings top forecasts
Datadog, Inc. (NASDAQ:DDOG) posted stronger-than-expected fourth-quarter results, triggering a sharp rally in its shares, which jumped 7.9% in premarket trading as investors welcomed the cloud monitoring firm’s performance and upbeat near-term revenue outlook. The AI-driven observability company reported adjusted earnings of $0.59 per share, beating the consensus estimate of $0.55. Quarterly revenue climbed 29% year…
-

Trimble tops Q4 forecasts on margin strength, shares tick higher
Trimble Inc. (NASDAQ:TRMB) delivered stronger-than-expected fourth-quarter results on Tuesday, supported by record margins and solid underlying growth, giving the stock a modest lift in premarket trading. Shares were up 0.48% ahead of the open. The technology group reported adjusted earnings of $1.00 per share for the quarter, beating the consensus forecast of $0.96. Revenue totaled…